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Abstract
Background: Conservative obesity treatment often leads to limited results. Bariatric surgery is highly efficient, but
the candidates are at risk of developing perioperative complications. Bariatric outcomes have been well described
in the past, but there are only few reports of perioperative outcomes.
The aim of this study was to evaluate the incidence of anaesthetic and surgical complications of Roux-en-Y bypass.
Methods: Data of all adult patients, who underwent primary Roux-en-Y gastric bypass surgery between 1/2006 and
12/2013 at the University Hospital Zurich were analysed. Using our clinical database, anaesthetic and surgical
complications during the first 30 days after surgery were analysed and risk factors determined by multivariate
analysis.
Results: Seven hundred eleven patients (72% female, median age 40 years) were analysed. Overall, surgical
complications occurred in 34% patient, while complications attributable to anaesthesia occurred in 37%.
Post-operative nausea and vomiting (PONV) were observed in 34%, intubation-related complications in 4%,
and delayed extubation in 2% of our patients. Within the first 30 days after surgery, 22% of the patients
presented with an infection. Gastrointestinal complications were found in 8%, and bleeding complications
in 3%. Anaesthesia complications were less common in older patients and in patients anaesthetized with a
volatile anaesthetic. Severe complications were more common in patients with a lower body mass index
(BMI) and with longer surgery. The risk to develop a postoperative infection was higher in diabetic patients.
Conclusion: Roux-en-Y bariatric surgery has few anaesthetic complications, the most common is PONV. PONV
is more common in younger patients and not more common with volatile anaesthetics. Major complications
are overall rare and occur in patients with lower BMI and longer surgery, likely reflecting more difficult procedures.
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Background
Obesity is a chronic and multifactorial disease with a
disproportional increase in adipose tissue. It is graded
into three classes: patients with a body mass index
(BMI) of 30.0–34.9 kg/m2 are referred to as obese pa-
tients class I, BMI 35.0–39.9 kg/m2 as class II, BMI > 40
kg/m2 as class III [1]. Class III patients may be further
subdivided into super obese patients, defined by a BMI
of > 45 or > 50 kg/m2 [2]. The prevalence of obesity has
doubled since 1980 [3], and is posing an increasing chal-
lenge to healthcare systems worldwide.
Conservative therapeutic approaches for obese patients
have led to limited results in terms of long-term weight
loss [4]. In contrast, bariatric surgery is an effective
treatment, which may reduce associated diseases such as
diabetes mellitus type 2 (T2DM), dyslipidaemia or ob-
structive sleep apnoea (OSAS) [5–14] and even mortality
rates of morbidly obese patients [7, 15].
Among the most frequently performed bariatric proce-
dures is the Roux-en-Y gastric bypass (RYGB) [16]. From
a surgical perspective, bariatric surgery in general and
RYGB in particular are characterized by a low surgical
risk profile and can be performed with low morbidity
and low mortality rates [7, 17]. From the perspective of
the anaesthesiologist however, only limited data exist re-
garding the perioperative anaesthesia risk and manage-
ment of patients with morbid obesity.
The aim of this prospectively collected retrospective
cohort analysis is to assess the anaesthesia and
surgery-related perioperative risk of obese patients
within the first 30 days after RYGB surgery at our uni-
versity centre between 2006 and 2013.
Methods
Data collection
After approval of the local ethics committee in Zurich
(Kantonale Ethikkomission Zurich, Switzerland, Chaired
by Peter Meier-Abt, KEK-ZH-No. 2015–0260; 14th of
July, 2015) we scanned the database of the bariatric sur-
gery in our centre well as our clinical databases (KISIM,
Cistec, Zürich) for all patients that underwent a primary
laparoscopic RYGB between 01/2006 and 12/2013. Pa-
tients with an age below 18 years and those that specific-
ally declared their unwillingness to have their clinical
data collected for research purposes were excluded.
For all other patients, patient characteristics (age, gen-
der, BMI, the American Society of Anesthesiologist, ASA,
physical status classification) as well as comorbidities
(arterial hypertension, T2DM, dyslipidaemia, obstructive
sleep apnoea syndrome, OSAS, chronic obstructive pul-
monary disease, COPD, and reflux/hiatal hernia) and
pre-existing medication were evaluated.
Surgery specific data were also analysed (surgery time,
the conversion rate to open surgery, and blood loss).
The anaesthesia specific characteristic’s included: anaes-
thesia duration, anaesthesia monitoring (arterial/ central
venous and pulmonary venous catheters), anaesthesia
medication (opioid, hypnotic agent, muscle relaxant, cate-
cholamines, and antihypertensives), method of intubation
(conventional laryngoscopy vs facilitated method with
SensaScope® or fiberoptic) and airway anatomy (Mallam-
pati and Cormack&Lehane classes), volume replacement
(crystalloid, colloid, packed red blood cells) and diuresis.
The following anaesthesia-related complications were
collected: intubation complications (unexpected difficult
airway, secondary change of intubation technique, failed
intubation), the need for re-intubation or delayed extu-
bation, complications related to catheter insertion and
positioning during surgery; medication-related adverse
reactions as well as the prevalence of postoperative nau-
sea and vomiting (PONV).
Intra- and postoperative surgical complications, as well
as complications within the first 30 days after the inter-
vention were registered according to the Clavien-Dindo
Classification [18]. The complications were classified by
type into gastrointestinal complications (e.g. anastomotic
stenosis or leak, incisional hernia, fluid collection and
anastomotic ulcer), infections (wound infections, general
infections, urinary tract infections, pneumonia), bleeding
complications, cardiovascular (tachycardia, myocardial
infarction), respiratory (pleural effusion), and renal com-
plications were monitored.
We also recorded the length of hospital stay, the num-
ber of days in the intensive care unit (ICU) and the
numbers of hospital re-admissions during the first 30
postoperative days.
RYGB surgery
All RYGB operations were performed laparoscopically
in a standardised way with the circular stapler tech-
nique for the gastro-enteral anastomosis as previously
described [19].
Statistical analyses
Statistic calculations were performed with GraphPad
Prism 6.0 for Mac (GraphPad Inc., La Jolla, CA), Micro-
soft Excel for Mac, Version 15.40 (Microsoft Corpor-
ation, Redmont, WA), and JMP 10.0.2 by SAS Institute,
Cary, N.C., USA. Data are presented as median and
interquartile range (IQR) for continuous nonparametric
data, and mean and standard deviation for parametric
data. Kolmogorov-Smirnov test was used to test for dis-
tribution. Categorical data were presented in percent-
ages. Missing data points are disclosed in the tables.
Outcomes of interest were identified and an univariate
analysis was performed with dichotomous covariates
using logistic regression. C-statistic was performed and
the Youden index was used to dichotomize continuous
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covariates. To correct for potential confounders, a multi-
variable model was constructed. Covariates with a sig-
nificant correlation in the univariate analyses (p < 0.1),
as well as covariates of clinical interest were included in
the model. A p-value < 0.05 was considered statistically
significant.
Results
In total, 712 patients underwent a primary standard lap-
aroscopic RYGB between 01/2006 and 12/2013. One sin-
gle patient had refused data collection for research
purposes and was thus excluded.
Patient and procedure characteristics
The median age was 40 (32–49) years with 72% female
and 28% male patients and a median BMI of 45 (41–49)
kg/m2. The patient’s anaesthesia-related risk was esti-
mated using the ASA classification. Four hundred and
sixteen patients (60%) patients were classified as ASA II,
278 (40%) as ASA III, 5 patients (1%) as ASA IV. Base-
line characteristics of patients, intraoperative surgery
and anesthesia parameters are summarized in Table 1.
The median duration of surgery was 145 (120–173)
minutes with a necessity for conversion to open surgery
in 10 (1%) patients and an estimated blood loss of 25
(10–50) ml.
The anaesthesia duration was 270 (235–310) minutes
with desflurane being the predominantly used anaes-
thetic for maintenance of anaesthesia in 89% of the pa-
tients. In 1% of the patients, sevoflurane and in 10%
propofol was used. The type of general anaesthetic was
determined by the responsible staff anaesthesiologist.
The most frequently used intubation method was a rapid
sequence induction and conventional laryngoscopy in
52% of the cases, followed by fibreoptic awake intub-
ation in 31%. Conventional induction with conventional
laryngoscopy was performed in 10%, in 6% with the Sen-
sascope® and in 1% as fibreoptic intubation.
Details about the patient’s co-medication and about
co-administered intraoperative drugs can be found in
Additional files 1 and 2.
Anaesthesia-related complications
The percentage of patients experiencing anaesthesia-re-
lated complications was 37%. The most prominent ad-
verse event was PONV with 34%, followed by
intubation/extubation-related complications (6%). Of
note is that some patients suffered from several complica-
tions, which explains why the sum of the different sub-
groups exceeds the overall number of patients with
complications.
Intubation-related events
4% of the patients experienced a complication related to
the intubation period. One (< 1%) patient had an aspiration,
and 1 (< 1%) patient suffered from a bronchospasm. Three
(< 1%) patients presented with a desaturation and another 3
(< 1%) had epistaxis due to the intubation manoeuvre, in 1
(< 1%) patient the tube was misplaced into the main bron-
chus and had to be withdrawn. An alternative (compared
to the planned) intubation procedure had to be established
in 2% of the patients: in 6 (1%) patients a fibreoptic proced-
ure was established instead of the conventional procedure,
in 3 (< 1%) patients a conventional intubation was favoured
over the planned fibreoptic method, and 2 (< 1%) patients
in whom a conventional intubation was unsuccessful, were
allowed to wake up, followed by an awake fibreoptic intub-
ation in a second approach.
Extubation-related events
Postoperative re-intubation was necessary in 3 (< 1%)
patients due to pulmonary decompensation in 2 patients
and bleeding from the surgical anastomosis in 1 patient.
Two percent of the patients were not extubated immedi-
ately after surgery, but on the ICU. The reason for the
prolonged weaning were difficult intubation in 1% of the
patients, difficulties to maintain an appropriate oxygen-
ation in 3 (< 1%) patients, unplanned conversion to open
surgery in 3 (< 1%) patients, over sedation in 1 (< 1%)
patient and planned delayed extubation because of
pre-existing medical conditions in 4 (1%) patients. De-
tails of patients with anaesthesia complications are given
in Additional file 3.
Airway problems and high BMI
The incidence of an in- and/ or extubation related event
was 6% in both groups: the super obese patients (BMI > 45
kg/m2) and patients with a BMI ≤ 45 kg/m2 (p = 0.9).
Adverse drug reactions
There were 4 (< 1%) patients with an adverse drug reac-
tion: 2 patients experienced a hypotension and rash due
to histamine liberation after atracurium use, 1 patient
presented with hypotension after infusion of metamizole
and 1 patient developed bronchospasm after infusion of
glycopyrronium-neostigmin for muscle relaxant reversal.
Even though 50% of the patients were administered
PONV prophylaxis, 34% of the patients suffering from
PONV.
Evaluation of predictors of anaesthesia complications
We evaluated the impact of patient age, duration of sur-
gery, BMI, ASA classification status, the type of anaes-
thesia, and catecholamine and PONV prophylaxis on the
occurrence of anaesthesia complications.
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Patients older than 35 (p < 0.001) and patients with
volatile anaesthetics (p < 0.001) had a lower likelihood to
experience anaesthetic complications at all, Table 2.
Patients older than 35 years had a lower incidence of
PONV (43 vs 29% OR 0.53, p < 0.001), PONV was more
frequent in females (38 vs 23%, OR 1.91, p < 0.001), and
less frequent when volatile anaesthesia was used (OR
0.31, p < 0.001), Table 3.
Surgical complications in the first 30 postoperative days
The number and the severity of complications ac-
cording to the Clavien-Dindo scoring system [18]
Table 1 Patient characteristics and intraoperative parameters related to surgery and anaesthesia
Full cohort n = 711 Missing data
Age (yrs.), median (IQR) 40 (32–49) 12
Sex, n (%) 12
Male 199 (28)
Female 500 (72)
BMI (kg/m2), median (IQR) 45 (41–49) 12
ASA, n (%) 12
II 416 (60)
III 278 (40)
IV 5 (1)
Comorbidities, n (%) 12
Hypertension 353 (50)
T2DM 200 (29)
Dyslipidaemia 89 (13)
OSAS 144 (21)
COPD 32 (5)
Reflux/hiatal hernia 352 (50)
Previous gastric banding, n (%) 83 (12) 12
Surgery time (min), median (IQR) 145 (120–173) 12
Gastric bypass, n (%) 25
Laparoscopic 676 (99)
Conversion to open 10 (1)
Blood loss (ml), median (IQR) 25 (10–50) 14
Monitoring, n (%) 12
Arterial Catheter 540 (77)
Central venous catheter 98 (14)
Pulmonary artery catheter 3 (< 1)
Intubation, n (%) 16
Rapid sequence induction, conventional laryngoscopy 360 (52)
Awake fibreoptic 215 (31)
Conventional induction, conventional laryngoscopy 69 (10)
Rapid sequence induction with Sensascope® 28 (4)
Conventional induction, with Sensascope® 13 (2)
Conventional induction, asleep fibreoptic 9 (1)
Mallampati, n (%) 228
I 146 (30)
II 216 (45)
III 100 (21)
IV 21 (4)
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(within the first 30 postoperative days) is given in
Table 4.
No surgical complication was observed in 66% of the
patients. Of the remaining patients, 5% had a complica-
tion grade I, 16% grade II, 6% grade IIIa and 7% grade
IIIb. There were no patients with grade IVa or IVb com-
plications, and no mortality (complication grade V).
Patients with Clavien-Dindo complications grade IIIb had
to be surgically reexplored for the following reasons: infec-
tions in 4% (n = 27), anastomotic leak in 1% (n = 8), haema-
toma evacuation or active bleeding in 1% (n = 7), incisional
hernia in 1% (n = 4). One patient had to undergo a trache-
ostomy because of respiratory insufficiency.
Detailed information about the type and number of
surgical complications within the first 30 days after
surgery is given in Additional file 4. We observed gastro-
intestinal, infectious, bleeding, and cardiovascular com-
plications in 8,22, 3, and 1% of patients respectively.
Respiratory and renal problems occurred in < 1% of the
patients and other problems occurred in 2% of the pa-
tients (pain, exanthema). It is important to note, that pa-
tients who developed more than one complication were
counted multiple times.
Evaluation of predictors of surgical complications
The impact of age, duration of surgery, BMI, T2DM, the
type of anaesthesia, and the use of catecholamines on
the occurrence of major surgical complications (defined
according Clavien-Dindo grade IIIb and higher) was ex-
amined. Multivariate analysis showed, that a lower BMI
was associated with higher incidence of major surgical
complications (15 vs 6%, OR 2.46, p = 0.04) and that a
procedure lasting longer than 170 min was associated
with more complications (12 vs. 5%, OR 0.44, p = 0.01),
Table 5.
As far as infectious complications are concerned, only
T2DM was associated with a higher incidence (20 vs.
29%, OR 1.60, p = 0.02), Table 6.
Hospitalisation and outcome characteristics
The median hospital stay was 7 (6–8) days for patients
after RYGB. The immediate postoperative transfer of the
patients to an ICU was necessary in 5% of the cases. In
all other cases patients could be extubated in the operat-
ing room (OR) and were monitored for a few hours or
overnight in the post anaesthesia care unit (PACU), the
intermediate care unit (IMC) or to the ICU, according
to availability of space. A second surgical intervention
within 30 days was necessary in 7% of the patients.
We found 37% patients with a complication related to
anaesthesia, in this group approximately one third (12%
of the patients) suffered from both: a complication re-
lated to anaesthesia and one related to surgery.
Table 2 Potential predictors of overall anaesthesia complications
(including PONV)
Covariate OR and CI p-value
Age (>35y) 0.55 (0.38–0.76) < 0.001*
Surgery time (> 130min) 1.26 (0.91–1.75) 0.2
BMI (> 44 kg/m2) 0.78 (0.55–1.07) 0.1
T2DM 1.02 (0.71–1.47) 0.9
Anaesthesia (volatile vs. i.v.) 0.31 (0.18–0.51) < 0.001*
Catecholamine use 1.01 80.67–1.52) 1.0
* indicates significant factors with a p < 0.05
Table 3 Potential predictors of PONV
Covariate OR and CI p-value
Age (> 35 years) 0.53 (0.37–0.76) < 0.001*
Gender (f vs. m) 1.91 (1.30–2.87) < 0.001*
Surgery time (> 130min) 1.28 (0.91–1.82) 0.15
BMI (> 44 kg/m2) 0.73 (0.52–1.02) 0.07
Anaesthesia (volatile vs. i.v.) 0.33 (0.20–0.56) < 0.001*
T2DM 1.00 (0.67–1.46) 1.0
Application of antiemetic drug 1.12 (0.80–1.57) 0.50
* indicates significant factors with a p < 0.05
Table 4 Patient’s highest complication according to Clavien-
Dindo classification within the first 30 days after surgery
Highest complication per patient
in the first 30 days according to
Clavien-Dindo classification
Full cohort, n = 711
n (%) Missing data (n)
None 452 (66) 22
With complication 237 (34) 22
I 36 (5) 22
II 113 (16) 22
IIIa 41 (6) 22
IIIb 47 (7) 22
IVa 0 (0) 22
IVb 0 (0) 22
V 0 (0) 22
Table 5 Potential predictors of major surgical complications
Covariate OR and CI p-value
Age (>42y) 0.85 (0.45–1.63) 0.6
Surgery time (> 170min) 2.27 (1.20–4.23) 0.01*
BMI (> 37 kg/m2) 0.46 (0.19–0.97) 0.04*
T2DM 1.42 (0.71–2.75) 0.3
Anaesthesia (volatile vs. i.v.) 1.01 (0.43–2.83) 1.0
Catecholamine use 0.74 (0.36–1.64) 0.4
* indicates significant factors with a p < 0.05
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Discussion
In this retrospective cohort study, we found that approxi-
mately one third of patients undergoing RYGB surgery in
a Swiss university hospital suffer from either an anaesthe-
sia- or surgery-related perioperative complications. The
vast majority of these complications are minor and there
was no mortality.
Anaesthesia-related complications
In contrast to peri- and postoperative surgery-related
morbidity after RYGB, for which a vast body of evidence
can be found in the literature, little is known about
anaesthesia-related complications. Only results from
smaller patient cohorts [20, 21] are available. The exist-
ing studies report an anaesthesia complication rate of
4% [20, 21]. In this prospective database, 4% of the pa-
tients experienced intubation-related complications,
while a previous study reported only 1% [21]. This differ-
ence may be due to differences in measurement. In this
study, for example the necessity for intermittent ventila-
tion prior to intubation due to a drop in oxygen satur-
ation was recorded as an event. In analogy to the
Clavien-Dindo classification, international consensus
definitions of anaesthesia complications are urgently
needed to be able to compare data of different studies.
With regard to extubation complications, the results
reported are in line with previous reports. Delayed extu-
bation occurred in 2% of the patients, other studies re-
ported 3–4% [20]. In this study, PONV accounted for
the highest number of anaesthesia-related complications.
As there are no other data available about the incidence
of PONV in RYGB, no comparison with the literature
was possible. Risk factors for PONV [22] are use of a
volatile anaesthetic, women and a young patient age.
Interestingly, we found a lower incidence of PONV in
patients anaesthetised with a volatile anaesthetic. As des-
flurane is our standard anaesthetic for RYGB surgery,
only patients with a history of PONV have received pro-
pofol anaesthesia and this might be the result of a selec-
tion bias. The database did not contain information
about previous anaesthetic complications to put this fac-
tor into the multivariate model. The use of an intraoper-
ative antiemetic did not reduce PONV incidence in the
multivariate analysis. Of note, any antiemetic or
prokinetic agent administered throughout the course of
anaesthesia was registered as antiemetic therapy (any
single or combined administration of metoclopramide,
mephamesone, droperidol, tropisetron, or ondansetron).
Only a systematic and effective PONV regimen imple-
mented at our institution has decreased PONV rates
from 51% in the first compared to 15% in the last year of
the observation period, which demonstrates the effective-
ness of this action (PONV rates over time and details
about PONV regimen are given in Additional file 5).
Surgery-related complications
Although at first sight the overall incidence of 34% of all
patients experiencing a complication related to surgery
appears high, the rate of specific complications in our
patient population is similar or even lower compared to
other studies. Stenosis of the gastrojejunostomy has been
previously reported to be as high as 9–25%, depending
on the technique, that has been used to facilitate the
gastrojejunostomy (circular vs. linear technique) [23].
Here, 3% of the patients experienced a stenosis of the
gastrojejunostomy in our population. We found a com-
parable incidence of leaks of the gastrojejunostomy in
1% of patients [24]. Wound infections were observed in
13% of the patients in our centre which is comparable to
9% documented in another study [25].
Of note, no patient died in this cohort (Clavien-Dindo
Complication V) while the mortality rate was previously
reported to be 0.18% [24] in a metanalysis and system-
atic review. This is an important achievement of this
program, given that the retrospective data analysis in-
cludes a learning curve starting in 2006 when the first
cases of RYGB were performed in our centre.
Potential risk-factors for developing major surgical
complications were evaluated. Interestingly, a lower
BMI resulted in a higher rate of major surgical com-
plications, which remains unexplained, but might be a
training phenomenon. A longer duration of the pro-
cedure resulted in more complications. Which is
likely a surrogate marker for a technically more chal-
lenging procedure or procedures performed by less
experienced surgeons.
The most common type of complications were infec-
tions, significantly more common in patients suffering
from T2DM. This is in accordance with other studies
reporting wound infections as the most common com-
plication and T2DM as an independent risk factor for
surgical site infection [26].
This study has several limitations. It is a single centre
retrospective analysis. There is an era bias since the ana-
lysis spans over 10 years. Surgical complications are col-
lected prospectively at our institution: this results in a
complete, yet sensitive database. Complications are
Table 6 Potential predictors of infections
Covariate OR and CI p-value
Age (>41y) 1.24 (0.84–1.82) 0.3
Gender (f vs. m) 1.50 (0.99–2.32) 0.05
Surgery time (> 165min) 1.45 (0.98–2.13) 0.06
BMI (> 48 kg/m2) 1.29 (0.86–1.91) 0.2
T2DM 1.60 (1.06–2.40) 0.02*
* indicates significant factors with a p < 0.05
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discussed weekly at the morbidity and mortality confer-
ence, which helps to uncover treatment problems and to
implement new treatment strategies. Nevertheless, an-
aesthetic complications after RYGB have not been re-
ported in much detail before and a large population has
been studied.
Conclusion
In conclusion, our findings suggest that bariatric surgery
is performed with low surgery- and anaesthesia-related
complication rates. As PONV is our most common an-
aesthesia complication, we conclude, that the factors af-
fecting PONV had a strong impact on the overall
predictors of anaesthesia complication. PONV was more
common in younger and female patients. The higher in-
cidence of PONV in the intravenous group is most likely
a result of a selection bias.
The majority of surgical complications were low grade
(IIIA or less). A higher incidence of severe complications
was observed in patients with a longer surgery and with
a lower BMI. Patients with T2DM have a higher risk of
infectious complications.
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